Volume 172, Issue 3 pp. 826-827
Correspondence

Improved psoriasis with weight loss: the role of behavioural factors

L.F. Sandoval

L.F. Sandoval

Department of Dermatology, Center for Dermatology Research, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC, 27157-1071 U.S.A

Search for more papers by this author
A. Pierce

A. Pierce

Department of Dermatology, Center for Dermatology Research, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC, 27157-1071 U.S.A

Search for more papers by this author
S.A. Davis

S.A. Davis

Department of Dermatology, Center for Dermatology Research, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC, 27157-1071 U.S.A

Search for more papers by this author
S.R. Feldman

S.R. Feldman

Department of Dermatology, Center for Dermatology Research, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC, 27157-1071 U.S.A

Department of Pathology, Center for Dermatology Research, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC, 27157-1071 U.S.A

Department of Public Health Sciences, Center for Dermatology Research, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC, 27157-1071 U.S.A

Search for more papers by this author
First published: 13 August 2014
Citations: 2
Funding sources: The Center for Dermatology Research is supported by an unrestricted educational grant from Galderma Laboratories, L.P.
Conflicts of interest: S.R.F. is a consultant and speaker for Galderma, Stiefel/GlaxoSmithKline, Abbott Labs, Warner Chilcott, Janssen, Amgen, Photomedex, Genentech, BiogenIdec and Bristol Myers Squibb. S.R.F. has received grants from Galderma, Astellas, Abbott Labs, Warner Chilcott, Janssen, Amgen, Photomedex, Genentech, BiogenIdec, Coria/Valeant, Pharmaderm, Ortho Pharmaceuticals, Aventis Pharmaceuticals, Roche Dermatology, 3M, Bristol Myers Squibb, Stiefel/GlaxoSmithKline, Novartis, Medicis, Leo, HanAll Pharmaceuticals, Celgene, Basilea and Anacor, and has received stock options from Photomedex. S.R.F. is the founder of and holds stock in Causa Research. L.F.S., A.P. and S.A.D. have no conflicts to report.
No abstract is available for this article.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.